Drugs
PHILADELPHIA, PA: Clinical Program on Track for Phase 2 Study of Once Monthly GLP-1 Analog
...
PARIS, FRANCE: Approximately 50 Percent More Patients on Lantus(R) Achieved Target HbA1c Versus Sitagliptin at Study Endpoint; EASIE Study Findings Published in The Lancet
...
PRINCETON, NJ: New Jersey Technology Council CFO Awards Recognize Accomplishments of New Jersey Financial Executives
...
HORSHAM, PA: Leading Analyst Firm Recognizes Substantial Cost Savings of eSource Business Model and Potential to Transform Clinical Trial Data Capture Processes
...
OSLO, NORWAY: Animal Studies Indicate Vacc-C5 Generates Immune Responses to HIV, Similar to Those in HIV Patients who Naturally Suppress the Virus
...
